Free Trial
OTCMKTS:BPSR

Organicell Regenerative Medicine (BPSR) Stock Price, News & Analysis

Organicell Regenerative Medicine logo
$2.18 -0.17 (-7.23%)
As of 04/28/2025

About Organicell Regenerative Medicine Stock (OTCMKTS:BPSR)

Key Stats

Today's Range
$2.18
$2.22
50-Day Range
$1.81
$3.01
52-Week Range
$0.04
$0.63
Volume
3,820 shs
Average Volume
3.31 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biotech Products Services & Research, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development of biological therapeutics for the treatment of degenerative diseases and to provide other related services. The firm also focuses on processing, distribution and supply of biologically processed cellular and tissue-based products developed from internally based research and development activities and also provides healthcare, anti-aging, and regenerative services. The company was founded by John Goodhew, Albert Mitrani and Maria Ines Mitrani on August 9, 2011 and is headquartered in Miami, FL.

Receive BPSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organicell Regenerative Medicine and its competitors with MarketBeat's FREE daily newsletter.

BPSR Stock News Headlines

Zeo ScientifiX, Inc. (ZEOX)
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Organicell Regenerative Medicine Inc (OCELD)
OCELD Organicell Regenerative Medicine, Inc.
Organicell Announces 1-for-200 Reverse Stock Split
See More Headlines

BPSR Stock Analysis - Frequently Asked Questions

Organicell Regenerative Medicine's stock was trading at $3.11 at the start of the year. Since then, BPSR stock has decreased by 29.9% and is now trading at $2.18.
View the best growth stocks for 2025 here
.

Shares of BPSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Organicell Regenerative Medicine investors own include Aurora Cannabis (ACB), NVIDIA (NVDA), 22nd Century Group (XXII), BioNTech (BNTX), Evofem Biosciences (EVFM), Inseego (INSG) and American Lithium (LIACF).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:BPSR
Fax
N/A
Employees
18
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (OTCMKTS:BPSR) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners